Related references
Note: Only part of the references are listed.Toxicity of Kava Kava
Peter P. Fu et al.
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2008)
Identification of five hepatotoxic pyrrolizidine alkaloids in a commonly used traditional Chinese medicinal herb, Herba Senecionis scandentis (Qianliguang)
Song-Lin Li et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts
J. Yan et al.
TOXICOLOGY AND INDUSTRIAL HEALTH (2008)
Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine
Qingsu Xia et al.
TOXICOLOGY LETTERS (2008)
Enforcement of the ban on aristolochic acids in Chinese traditional herbal preparations on the Dutch market
Martijn J. Martena et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Relaxation effects of ligustilide and senkyunolide A, two main constituents of Ligusticum chuanxiong, in rat isolated aorta
Sunny Sun-Kin Chan et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Ginkgo biloba leave extract:: Biological, medicinal, and toxicological effects
Po-Chuen Chan et al.
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2007)
Post-harvest alteration of the main chemical ingredients in Ligusticum chuanxiong HoRT. (Rhizoma chuanxiong)
Song-Lin Li et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2007)
Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract
Natasha P. Clayton et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2007)
Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats
Tao Chen et al.
BMC BIOINFORMATICS (2006)
Studies on the reproductive, cytological and biochemical toxicity of Ginkgo biloba in Swiss albino mice
Abdulaziz A. Al-Yahya et al.
JOURNAL OF ETHNOPHARMACOLOGY (2006)
Mutations induced by carcinogenic doses of aristolochic acid in kidney of Big Blue transgenic rats
Ling Chen et al.
TOXICOLOGY LETTERS (2006)
Time-course accumulation of main bioactive components in the rhizome of Ligusticum chuanxiong
SL Li et al.
PLANTA MEDICA (2006)
Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, lasiocarpine
QS Xia et al.
CANCER LETTERS (2006)
Aristolochic acids detected in some raw chinese medicinal herbs and manufactured herbal products - A consequence of inappropriate nomenclature and imprecise labelling?
Thomas P. Cheung et al.
CLINICAL TOXICOLOGY (2006)
The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin-induced toxicity
AW Boots et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Formation of transient covalent protein and DNA adducts by quercetin in cells with and without oxidative enzyme activity
H van der Woude et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
Pharmacokinetics and disposition of the kavalactone kawain: Interaction with kava extract and kavalactones in vivo and in vitro
JM Mathews et al.
DRUG METABOLISM AND DISPOSITION (2005)
Potential for interaction of kava and St. John's wort with drugs
YN Singh
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo
YP Wang et al.
CANCER LETTERS (2005)
Spontaneous bleeding associated with Ginkgo biloba -: A case report and systematic review of the literature
S Bent et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2005)
Systematic evaluation of organochlorine pesticide residues in Chinese materia medica
KSY Leung et al.
PHYTOTHERAPY RESEARCH (2005)
Long-term. combined administration of quercetin and daidzein inhibits quercetin-induced suppression of glutathione antioxidant defenses.
EJ Choi et al.
FOOD AND CHEMICAL TOXICOLOGY (2005)
Tumour induction in rats following exposure to short-term high dose aristolochic acid I
M Cui et al.
MUTAGENESIS (2005)
Herb-drug interactions - A literature review
ZP Hu et al.
DRUGS (2005)
Initiative targets faculty recruiting
PS Zurer
CHEMICAL & ENGINEERING NEWS (2004)
Kava kava: examining new reports of toxicity
DL Clouatre
TOXICOLOGY LETTERS (2004)
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy
GM Lord et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid
H Zhang et al.
FOOD AND CHEMICAL TOXICOLOGY (2004)
Pyrrolizidine alkaloids - Genotoxicity, metabolism enzymes, metabolic activation, and mechanisms
PP Fu et al.
DRUG METABOLISM REVIEWS (2004)
Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer
VM Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Metabolic formation of DHP-derived DNA adducts from a representative otonecine type pyrrolizidine alkaloid clivorine and the extract of Ligularia hodgsonnii hook
QS Xia et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert
LS Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Toxicity and carcinogenicity of riddelline in rats and mice
PC Chan et al.
TOXICOLOGY LETTERS (2003)
Kava lactones and the kava-kava controversy
PA Whitton et al.
PHYTOCHEMISTRY (2003)
Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid
MW Chou et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
Hepatitis induced by Kava (Piper methysticum rhizoma)
F Stickel et al.
JOURNAL OF HEPATOLOGY (2003)
Identification of novel electrophilic metabolites of Piper methysticum Forst. (Kava)
BM Johnson et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells
T Walle et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice
MW Chou et al.
CANCER LETTERS (2003)
Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure
JL Nortier et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine
QS Xia et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2003)
Acute hepatitis induced by kava kava
CL Humberston et al.
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2003)
Inhibition of human cytochrome P450 activities by kava extract and kavalactones
JM Mathews et al.
DRUG METABOLISM AND DISPOSITION (2002)
Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity
L Zou et al.
LIFE SCIENCES (2002)
Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy
AJ Cronin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Urothelial malignant disease and Chinese herbal nephropathy
GM Lord et al.
LANCET (2001)
Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy?
JP Cosyns et al.
KIDNEY INTERNATIONAL (2001)
Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo
YC Yang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR
VM Arlt et al.
CARCINOGENESIS (2001)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide
MG Boersma et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)
Distinct mechanisms of DNA damage in apoptosis induced by quercetin and luteolin
N Yamashita et al.
FREE RADICAL RESEARCH (2000)
Share Paper
